Detalhe da pesquisa
1.
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
J Am Soc Nephrol
; 35(3): 311-320, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261535
2.
Toward evidence-based communication on overweight body mass index and mortality.
BMC Med
; 22(1): 183, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693530
3.
Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Hum Reprod
; 39(3): 526-537, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243752
4.
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).
Lancet
; 399(10343): 2267-2279, 2022 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717987
5.
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Nephrol Dial Transplant
; 38(6): 1448-1458, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331426
6.
Metabolic Basis and Pathogenesis of Skeletal Muscle Dysfunction as Cause of Frailty in Chronic Kidney Disease.
Am J Nephrol
; 53(10): 740-752, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473450
7.
Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists.
Am J Nephrol
; 53(10): 722-729, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477582
8.
Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
Am J Nephrol
; 53(8-9): 603-613, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349769
9.
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.
Nephrol Dial Transplant
; 37(7): 1302-1309, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240198
10.
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
BMC Nephrol
; 23(1): 82, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216581
11.
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
J Am Soc Nephrol
; 32(1): 211-222, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272965
12.
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Drug Metab Dispos
; 49(7): 490-500, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031138
13.
Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
BMC Nephrol
; 22(1): 185, 2021 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011303
14.
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
Lancet
; 393(10179): 1417-1427, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857647
15.
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
Lancet
; 394(10196): 396-406, 2019 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248662
16.
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
N Engl J Med
; 373(25): 2413-24, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559317
17.
Primary Care Physicians' Perceptions of the Effects of Being Overweight on All-cause Mortality.
Epidemiology
; 34(3): e19-e20, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727941
18.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
Am J Nephrol
; 46(6): 450-458, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253847
19.
Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over Time.
Kidney Med
; 5(1): 100573, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683962
20.
Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study.
Kidney Med
; 5(5): 100622, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139081